Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765648 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 226
- Enrollment target
NCT00765648: Completed Phase 4 study, sponsored by The Cleveland Clinic.
NCT00765648 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 226 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00765648, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 226 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of Cardene I.V. to labetalol administered intravenously for the management of hypertension in the emergency department setting.
Primary Outcome
Percentage of subjects achieving a pre-defined target systolic blood pressure (BP) range defined as a systolic blood pressure that is within +/- 20 mmHg of the target as established by the investigator.
Interventions
- DRUG Labetalol
- DRUG nicardipine intravenous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
What the finished NCT00765648 record still lists
NCT00765648 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Labetalol is the first listed.
NCT00765648 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00765648 about?
NCT00765648 is a clinical study titled "Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department". The purpose of this study is to compare the safety and efficacy of Cardene I.V. to labetalol administered intravenously for the management of hypertension in the emergency department setting.
What is the current status of trial NCT00765648?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 226 participants. The study started on 2008-10. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00765648?
The interventions under investigation include: Labetalol (DRUG), nicardipine intravenous (DRUG).
Who is sponsoring clinical trial NCT00765648?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00765648's enrollment target sits among peer trials
226 376th of 2000 higher than 1,622 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04419272 · 226 participants · Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- NCT05449002 · 226 participants · NA
Digital Single Session Intervention for Youth Mental Health
- NCT05488054 · 226 participants · NA
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
- NCT05924477 · 226 participants · NA
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia